Edwards Lifesciences Corp (EW) earnings date

NYSE · Large cap · EDGAR filings

Email me when this date changes · free account, one click to stop

How this company behaves

Announces its report date Not enough announcements on file yet to say
Reports after the quarter ends 27 days, typically, give or take 8 (last 8 releases)

Last 8 releases

PeriodReleasedTimingDays after period endFiling
Q3 FY2026Wed, Nov 4, 2026after close 35 8-K
Q2 FY2026Thu, Jul 23, 2026after close 23 8-K
Q1 FY2026Thu, Apr 23, 2026after close 23 8-K
Q4 FY2025Tue, Feb 10, 2026after close 41 8-K
Q3 FY2025Thu, Oct 30, 2025after close 30 8-K
Q2 FY2025Thu, Jul 24, 2025after close 24 8-K
Q1 FY2025Wed, Apr 23, 2025after close 23 8-K
Q4 FY2024Tue, Feb 11, 2025after close 42 8-K

What they guided beta

Q3 FY2026 "Q3 EPS of $0.53 1 ; adjusted 2 EPS of $0.80 1 which grew 19% versus prior year 2026 Outlook" exhibit
Q3 FY2026 "U.S. approval of AUTUS addresses lifelong needs of pediatric patients with congenital heart disease “We delivered strong third-quarter growth of 11.2% which exceeded expectations, with broad-based performance across our businesses and regions, giving us the confidence to raise our full-year outlook,” said Bernard Zovighian, CEO of Edwards Lifesciences." exhibit
Q3 FY2026 "The company continues to expect adjusted gross profit margin to be at the lower end of its full-year 78% to 79% gross margin guidance, driven by the impacts of currency fluctuations through the company’s hedging program." exhibit
Q3 FY2026 "The company expects R&D expense as a percentage of sales to be approximately 16.5% in 2026. 4 Operating profit margin in the third quarter was 17.4%, or 30.3% adjusted." exhibit
Q3 FY2026 "In 2026, Edwards continues to expect full-year operating profit margin to be at the high end of the company’s original 28% to 29% guidance range, resulting in approximately 150 basis points of constant currency operating margin expansion for the full year." exhibit
Q2 FY2026 "Recent clinical data at New York Valves reinforce best-in-class SAPIEN performance and durability; PASCAL, EVOQUE and SAPIEN M3 differentiated body of clinical evidence continues to expand 2026 Outlook" exhibit
Q2 FY2026 "Expected Q4 approvals of PASCAL tricuspid indication in U.S. and next-generation PASCAL with Capture Clarity in U.S. and Europe “We delivered stronger-than-expected second quarter sales growth of 12.5%." exhibit
Q2 FY2026 "The company continues to expect that its next- 2 generation PASCAL with Capture Clarity technology for both mitral and tricuspid patients in the U.S. and Europe will be approved in the fourth quarter." exhibit
Q2 FY2026 "The company now expects gross profit margin to be at the lower end of its full-year 78% to 79% gross margin guidance, driven by the impacts of foreign exchange through its hedging program." exhibit
Q2 FY2026 "The company continues to expect R&D expense as a percentage of sales to be approximately 17% in 2026." exhibit

Get this as JSON

curl -H "X-API-Key: vt_live_..." https://api.veritasdata.dev/v1/next/EW
# how far back the record goes for this company
curl -H "X-API-Key: vt_live_..." https://api.veritasdata.dev/v1/coverage/EW

Put this date on your page

A badge that stays current. It links back to this page and needs no key. Embed it unmodified, with its link to this page intact: the badge is too small to carry the notice below, so the page it links to does.

Read by software from public filings and company announcements. Can be wrong. Verify with the company or the SEC. Not investment advice.

EW earnings date badge

HTML

<a href="https://veritasdata.dev/company/EW/"><img src="https://veritasdata.dev/embed/EW.svg" alt="EW earnings date" width="240" height="56"></a>

Markdown

[![EW earnings date](https://veritasdata.dev/embed/EW.svg)](https://veritasdata.dev/company/EW/)

Script

<script async src="https://veritasdata.dev/embed/EW.js"></script>

Get a free key: 100 calls, every company

Sign in with GitHub or Google. The key works on every endpoint and in the MCP server.

curl -H "X-API-Key: vt_live_..." "https://api.veritasdata.dev/v1/next/EW"

Dates come only from SEC EDGAR and company announcements. Nothing here is investment advice.